Skip to Main Content

Paper Details

Comparison of 71 bipolar disorder pharmacotherapies for kidney disorder risk: The potential hazards of polypharmacy.
J Affect Disord
5
2019
Author NameAffiliation
Anastasiya NestsiarovichCenter for Global Health, University of New Mexico Health Sciences Center
Anastasiya NestsiarovichCenter for Global Health, University of New Mexico Health Sciences Center
Berit KernerSemel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California los angeles
Aurélien Mazurie
Daniel C Cannon
Nathaniel G HurwitzNew Mexico Behavioral Health Institute
Yiliang ZhuUniversity of New Mexico Health Sciences Center
Stuart J NelsonUniversity of New Mexico Health Sciences Library and Informatics Center, University of New Mexico Health Sciences Center
Tudor I OpreaUniversity of New Mexico Health Sciences Center
Tudor I OpreaUniversity of New Mexico Health Sciences Center
Mark UnruhUniversity of New Mexico Health Sciences Center
Annette S CrisantiUniversity of New Mexico Health Sciences Center
Mauricio TohenUniversity of New Mexico Health Sciences Center
Douglas J PerkinsCenter for Global Health, University of New Mexico Health Sciences Center
Christophe G LambertCenter for Global Health, University of New Mexico Health Sciences Center
Christophe G LambertCenter for Global Health, University of New Mexico Health Sciences Center
  • 1 - 16

Datasets